Is Exact Sciences Corporation (EXAS) a Buy, Sell, or Hold?
Enter your email address below for free access to our Exact Sciences Corporation (EXAS) research center and poll results.
Exact Sciences Corporation
NASDAQ:EXAS
$104.91 USD
$0 (0.0%)
- Volume
- 21.56M
- Average Volume
- 2.53M
- Market Capitalization
- $20.03B
- P/E Ratio
- -95.69
- Dividend Yield
- 0.00%
- Price Target
- $105.00
- Year High
- $104.98
- Year Low
- $38.81
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.23
| Source | Headline |
|---|---|
|
Abbott Laboratories Q2 Earnings Preview: A Contrarian Buy Opportunity Worth Considering
Abbott Laboratories is upgraded to Buy ahead of Q2 2026 earnings, following a challenging period marked by share price underperformance. The recent acquisition of Exact Sciences adds a high-growth cancer diagnostics vertical, targeting $3bn incremental 2026 sales and potential long-term revenue expansion. 2026 guidance projects 6.5–7.5% organic sales growth and $5.38–$5.58 adjusted EPS, with Exact Sciences acquisition causing $0.20 EPS dilution. seekingalpha.com - 2026-07-03 16:00:00 |
|
Abbott Labs shares fall as earnings beat offset by Exact Sciences acquisition drag
Shares of Abbott Laboratories (NYSE:ABT) fell 3.2% on Thursday morning after the healthcare conglomerate marginally beat Wall Street estimates for quarterly profit and revenue, but flagged a hit to its 2026 earnings outlook from its recently completed cancer diagnostics acquisition. Investors weighed near-term earnings strength against dilution from the company's roughly $23 billion acquisition of Exact Sciences. proactiveinvestors.com - 2026-04-16 10:51:58 |
Get EXAS Insider Trade Alerts
Sign up for InvestorConsensus.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.
Market Data and Calendars
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
EXAS Price Target Summary
Last Month
$0.00
0 analystsLast Quarter
$0.00
0 analystsLast Year
$89.32
19 analystsAll Time
$91.38
50 analystsEXAS Recent Analyst Grades
| Date | Analyst Firm | Action | Previous Grade | New Grade |
|---|---|---|---|---|
| 2026-01-20 | Mizuho | Downgrade | Outperform | Neutral |
| 2026-01-05 | Evercore ISI Group | Downgrade | Outperform | In Line |
| 2025-11-28 | Stifel | Downgrade | Buy | Hold |
| 2025-11-25 | Canaccord Genuity | Downgrade | Buy | Hold |
| 2025-11-24 | Jefferies | Downgrade | Buy | Hold |
| 2025-11-24 | Benchmark | Downgrade | Buy | Hold |
| 2025-11-21 | Wells Fargo | Downgrade | Overweight | Equal Weight |
| 2025-11-21 | William Blair | Downgrade | Outperform | Market Perform |
| 2025-11-21 | Barclays | Downgrade | Overweight | Equal Weight |
| 2025-11-21 | Guggenheim | Downgrade | Buy | Neutral |
| 2025-11-20 | BTIG | Downgrade | Buy | Neutral |
| 2025-11-11 | Piper Sandler | Maintain | Overweight | Overweight |
| 2025-11-05 | Wells Fargo | Maintain | Overweight | Overweight |
| 2025-11-04 | Barclays | Maintain | Overweight | Overweight |
| 2025-11-04 | BTIG | Maintain | Buy | Buy |
| 2025-11-04 | Benchmark | Maintain | Buy | Buy |
| 2025-11-04 | Guggenheim | Maintain | Buy | Buy |
| 2025-11-04 | Stifel | Maintain | Buy | Buy |
| 2025-11-04 | Baird | Maintain | Outperform | Outperform |
| 2025-11-04 | TD Cowen | Maintain | Buy | Buy |
| 2025-10-22 | BTIG | Maintain | Buy | Buy |
| 2025-10-08 | Piper Sandler | Maintain | Overweight | Overweight |
| 2025-10-07 | Evercore ISI Group | Maintain | Outperform | Outperform |
| 2025-10-02 | Barclays | Maintain | Overweight | Overweight |
| 2025-09-11 | Craig-Hallum | Maintain | Buy | Buy |
| 2025-08-12 | BTIG | Maintain | Buy | Buy |
| 2025-08-11 | Piper Sandler | Maintain | Overweight | Overweight |
| 2025-08-08 | Evercore ISI Group | Maintain | Outperform | Outperform |
| 2025-08-07 | RBC Capital | Maintain | Sector Perform | Sector Perform |
| 2025-08-07 | Barclays | Maintain | Overweight | Overweight |
| 2025-08-07 | UBS | Maintain | Neutral | Neutral |
| 2025-07-08 | Evercore ISI Group | Maintain | Outperform | Outperform |
| 2025-06-24 | Barclays | Maintain | Overweight | Overweight |
| 2025-05-02 | Barclays | Maintain | Overweight | Overweight |
| 2025-05-02 | Baird | Maintain | Outperform | Outperform |
| 2025-05-02 | Evercore ISI Group | Maintain | Outperform | Outperform |
| 2025-05-02 | RBC Capital | Maintain | Sector Perform | Sector Perform |
| 2025-04-11 | Guggenheim | Maintain | Buy | Buy |
| 2025-04-10 | Barclays | Maintain | Overweight | Overweight |
| 2025-02-26 | Piper Sandler | Maintain | Overweight | Overweight |
| 2025-02-24 | Scotiabank | Maintain | Sector Outperform | Sector Outperform |
| 2025-02-20 | B of A Securities | Maintain | Buy | Buy |
| 2025-02-20 | Barclays | Maintain | Overweight | Overweight |
| 2025-01-13 | Benchmark | Maintain | Buy | Buy |
| 2024-12-13 | B of A Securities | Maintain | Buy | Buy |
| 2024-11-26 | BTIG | Maintain | Buy | Buy |
| 2024-11-26 | TD Cowen | Maintain | Buy | Buy |
| 2024-11-11 | Piper Sandler | Maintain | Overweight | Overweight |
| 2024-11-06 | Citigroup | Maintain | Buy | Buy |
| 2024-11-06 | Evercore ISI Group | Maintain | Outperform | Outperform |
| 2024-11-06 | Jefferies | Maintain | Buy | Buy |
| 2024-11-06 | Craig-Hallum | Maintain | Buy | Buy |
| 2024-11-06 | TD Cowen | Maintain | Buy | Buy |
| 2024-11-06 | Baird | Maintain | Outperform | Outperform |
| 2024-11-06 | Benchmark | Maintain | Buy | Buy |
| 2024-11-06 | Goldman Sachs | Maintain | Buy | Buy |
| 2024-11-06 | Stifel | Maintain | Buy | Buy |
| 2024-11-06 | BTIG | Maintain | Buy | Buy |
| 2024-11-06 | Canaccord Genuity | Maintain | Buy | Buy |
| 2024-10-30 | Bernstein | Maintain | Outperform | Outperform |
| 2024-10-29 | Canaccord Genuity | Maintain | Buy | Buy |
| 2024-10-01 | Evercore ISI Group | Maintain | Outperform | Outperform |
| 2024-09-13 | Canaccord Genuity | Maintain | Buy | Buy |
| 2024-09-12 | Piper Sandler | Maintain | Overweight | Overweight |
| 2024-08-01 | Benchmark | Maintain | Buy | Buy |
| 2024-08-01 | Stifel | Maintain | Buy | Buy |
| 2024-07-17 | Goldman Sachs | Maintain | Buy | Buy |
| 2024-07-02 | Evercore ISI Group | Maintain | Outperform | Outperform |
| 2024-06-27 | BTIG | Maintain | Buy | Buy |
| 2024-06-26 | BTIG | Maintain | Buy | Buy |
| 2024-05-09 | Citigroup | Maintain | Buy | Buy |
| 2024-05-09 | BTIG | Maintain | Buy | Buy |
| 2024-05-09 | Canaccord Genuity | Maintain | Buy | Buy |
| 2024-04-03 | Citigroup | Maintain | Buy | Buy |
| 2024-02-22 | Canaccord Genuity | Maintain | Buy | Buy |
| 2024-01-02 | Benchmark | Upgrade | Hold | Buy |
| 2023-11-03 | Goldman Sachs | Maintain | Buy | Buy |
| 2023-10-16 | Piper Sandler | Maintain | Overweight | Overweight |
| 2023-10-10 | Piper Sandler | Upgrade | Neutral | Overweight |
| 2023-08-08 | Piper Sandler | Maintain | Neutral | Neutral |
| 2023-08-03 | Jefferies | Maintain | Buy | Buy |
| 2023-08-02 | Credit Suisse | Maintain | Neutral | Neutral |
| 2023-08-02 | Benchmark | Downgrade | Buy | Hold |
| 2023-08-02 | Baird | Maintain | Outperform | Outperform |
| 2023-07-24 | Goldman Sachs | Maintain | Buy | Buy |
| 2023-07-21 | Goldman Sachs | Maintain | Buy | Buy |
| 2023-06-23 | Canaccord Genuity | Maintain | Buy | Buy |
| 2023-06-22 | Citigroup | Maintain | Buy | Buy |
| 2023-06-22 | Benchmark | Maintain | Buy | Buy |
| 2023-06-21 | Canaccord Genuity | Maintain | Buy | Buy |
| 2023-06-21 | Stifel | Maintain | Buy | Buy |
| 2023-06-07 | Jefferies | Maintain | Buy | Buy |
| 2023-05-11 | Citigroup | Maintain | Buy | Buy |
| 2023-05-10 | Baird | Maintain | Outperform | Outperform |
| 2023-05-10 | Jefferies | Maintain | Buy | Buy |
| 2023-05-10 | B of A Securities | Maintain | Buy | Buy |
| 2023-05-10 | Craig-Hallum | Upgrade | Hold | Buy |
| 2023-05-10 | Credit Suisse | Maintain | Neutral | Neutral |
| 2023-05-05 | UBS | Maintain | Neutral | Neutral |
| 2023-03-15 | Benchmark | Maintain | Buy | Buy |
| 2023-03-09 | Citigroup | Upgrade | Neutral | Buy |
| 2023-03-03 | Piper Sandler | Maintain | Neutral | Neutral |
| 2023-02-22 | Canaccord Genuity | Maintain | Buy | Buy |
| 2023-02-22 | BTIG | Maintain | Buy | Buy |
| 2023-02-22 | Citigroup | Maintain | Neutral | Neutral |
| 2023-02-22 | Baird | Maintain | Outperform | Outperform |
| 2023-02-22 | Cowen & Co. | Maintain | Outperform | Outperform |
| 2023-02-22 | Credit Suisse | Maintain | Neutral | Neutral |
| 2023-02-10 | Credit Suisse | Downgrade | Outperform | Neutral |
| 2023-01-18 | Raymond James | Downgrade | Outperform | Market Perform |
| 2023-01-12 | SVB Leerink | Maintain | Outperform | Outperform |
| 2023-01-06 | SVB Leerink | Maintain | Outperform | Outperform |
| 2022-12-16 | Jefferies | Maintain | Buy | Buy |
| 2022-11-14 | Piper Sandler | Maintain | Neutral | Neutral |
| 2022-11-08 | Raymond James | Maintain | Outperform | Outperform |
| 2022-11-07 | BTIG | Maintain | Buy | Buy |
| 2022-10-19 | Craig-Hallum | Downgrade | Buy | Hold |
| 2022-08-25 | Credit Suisse | Maintain | Outperform | Outperform |
| 2022-08-17 | Piper Sandler | Maintain | Overweight | Overweight |
| 2022-08-03 | Baird | Maintain | Outperform | Outperform |
| 2022-08-03 | Citigroup | Maintain | Neutral | Neutral |
| 2022-08-03 | Cowen & Co. | Maintain | Outperform | Outperform |
| 2022-08-03 | BTIG | Maintain | Buy | Buy |
| 2022-08-03 | Raymond James | Maintain | Outperform | Outperform |
| 2022-08-03 | Craig-Hallum | Maintain | Buy | Buy |
| 2022-06-03 | Piper Sandler | Maintain | Neutral | Neutral |
| 2022-04-27 | SVB Leerink | Maintain | Outperform | Outperform |
| 2022-04-27 | Raymond James | Maintain | Outperform | Outperform |
| 2022-04-27 | B of A Securities | Maintain | Buy | Buy |
| 2022-04-19 | Goldman Sachs | Maintain | Buy | Buy |
| 2022-02-23 | Wells Fargo | Maintain | Equal Weight | Equal Weight |
| 2022-02-23 | SVB Leerink | Maintain | Outperform | Outperform |
| 2022-02-23 | Citigroup | Maintain | Neutral | Neutral |
| 2022-02-23 | Raymond James | Maintain | Outperform | Outperform |
| 2021-11-03 | Raymond James | Downgrade | Strong Buy | Outperform |
| 2021-11-03 | Wells Fargo | Maintain | Equal Weight | Equal Weight |
| 2021-11-03 | SVB Leerink | Maintain | Outperform | Outperform |
| 2021-07-29 | Canaccord Genuity | Maintain | Buy | Buy |
| 2021-07-29 | Oppenheimer | Maintain | Outperform | Outperform |
| 2021-07-14 | SVB Leerink | Maintain | Outperform | Outperform |
| 2021-06-21 | Wells Fargo | Maintain | Equal Weight | Equal Weight |
| 2021-06-15 | Raymond James | Downgrade | Strong Buy | Buy |
| 2021-06-03 | Goldman Sachs | Maintain | Buy | Buy |
| 2021-05-25 | Wells Fargo | Maintain | Equal Weight | Equal Weight |
| 2021-05-12 | Truist Securities | Maintain | Buy | Buy |
| 2021-05-05 | SVB Leerink | Maintain | Outperform | Outperform |
| 2021-02-17 | SVB Leerink | Maintain | Outperform | Outperform |
| 2021-02-17 | Cowen & Co. | Maintain | Outperform | Outperform |
| 2021-02-17 | Stifel | Maintain | Buy | Buy |
| 2021-01-28 | Truist Securities | Maintain | Buy | Buy |
| 2021-01-21 | SVB Leerink | Maintain | Outperform | Outperform |
| 2020-10-29 | UBS | Downgrade | Buy | Neutral |
| 2020-10-28 | Citigroup | Downgrade | Buy | Neutral |
| 2020-10-28 | Benchmark | Maintain | Buy | Buy |
| 2020-10-28 | SVB Leerink | Maintain | Outperform | Outperform |
| 2020-10-28 | Canaccord Genuity | Maintain | Buy | Buy |
| 2020-09-25 | Canaccord Genuity | Maintain | Buy | Buy |
| 2020-07-31 | SVB Leerink | Maintain | Outperform | Outperform |
| 2020-06-25 | Citigroup | Maintain | Buy | Buy |
| 2020-05-07 | Baird | Maintain | Outperform | Outperform |
| 2020-05-07 | B of A Securities | Maintain | Buy | Buy |
| 2020-05-07 | SVB Leerink | Maintain | Outperform | Outperform |
| 2020-04-28 | UBS | Maintain | Buy | Buy |
| 2020-04-22 | Citigroup | Maintain | Buy | Buy |
| 2020-04-02 | Evercore ISI Group | Maintain | Outperform | Outperform |
| 2020-04-02 | Stifel | Maintain | Buy | Buy |
| 2020-01-07 | Citigroup | Maintain | Buy | Buy |
| 2019-11-15 | Stifel Nicolaus | Maintain | Buy | Buy |
| 2019-10-30 | Canaccord Genuity | Maintain | Buy | Buy |
| 2019-10-30 | Baird | Maintain | Outperform | Outperform |
| 2019-10-30 | UBS | Maintain | Buy | Buy |
| 2019-10-17 | Bank of America | Maintain | Buy | Buy |
| 2019-10-17 | B of A Securities | Maintain | Buy | Buy |
| 2019-09-26 | Oppenheimer | Maintain | Outperform | Outperform |
| 2019-09-23 | Benchmark | Upgrade | Hold | Buy |
| 2019-08-01 | UBS | Maintain | Buy | Buy |
| 2019-05-01 | UBS | Maintain | Buy | Buy |
| 2019-05-01 | Canaccord Genuity | Maintain | Buy | Buy |
| 2019-04-16 | UBS | Maintain | Buy | Buy |
| 2019-04-12 | Goldman Sachs | Maintain | Buy | Buy |
| 2019-02-26 | Goldman Sachs | Upgrade | Neutral | Buy |
| 2018-10-31 | Jefferies | Maintain | Buy | Buy |
| 2018-09-12 | Canaccord Genuity | Maintain | Buy | Buy |
| 2018-09-11 | Baird | Maintain | Outperform | Outperform |
| 2018-09-06 | Bank of America | Maintain | Buy | Buy |
| 2018-09-06 | B of A Securities | Maintain | Buy | Buy |
| 2018-08-23 | Baird | Maintain | Outperform | Outperform |
| 2018-08-02 | B of A Securities | Maintain | Buy | Buy |
| 2018-08-02 | Jefferies | Maintain | Buy | Buy |
| 2018-08-02 | Bank of America | Maintain | Buy | Buy |
| 2018-07-23 | Bank of America | Maintain | Buy | Buy |
| 2018-07-23 | B of A Securities | Maintain | Buy | Buy |
| 2018-07-19 | Leerink Swann | Maintain | Outperform | Outperform |
| 2018-07-09 | Baird | Maintain | Outperform | Outperform |
| 2018-06-06 | Canaccord Genuity | Maintain | Buy | Buy |
| 2018-06-05 | Baird | Maintain | Outperform | Outperform |
| 2018-05-31 | Canaccord Genuity | Maintain | Buy | Buy |
| 2018-04-27 | Canaccord Genuity | Maintain | Buy | Buy |
| 2018-04-03 | BTIG Research | Upgrade | Neutral | Buy |
| 2018-04-03 | BTIG | Upgrade | Neutral | Buy |
| 2018-02-27 | Baird | Upgrade | Neutral | Outperform |
| 2018-02-23 | Benchmark | Downgrade | Buy | Hold |
| 2018-01-29 | Goldman Sachs | Maintain | Neutral | Neutral |
| 2017-11-13 | Leerink Swann | Maintain | Outperform | Outperform |
| 2017-11-13 | Baird | Downgrade | Outperform | Neutral |
| 2017-11-01 | BTIG Research | Downgrade | Buy | Neutral |
| 2017-11-01 | BTIG | Downgrade | Buy | Neutral |
| 2017-10-31 | B of A Securities | Maintain | Buy | Buy |
| 2017-10-31 | Leerink Swann | Maintain | Outperform | Outperform |
| 2017-10-31 | Baird | Maintain | Outperform | Outperform |
| 2017-10-31 | Bank of America | Maintain | Buy | Buy |
| 2017-10-19 | B of A Securities | Maintain | Buy | Buy |
| 2017-10-19 | Bank of America | Maintain | Buy | Buy |
| 2017-10-03 | Canaccord Genuity | Maintain | Buy | Buy |
| 2017-09-21 | Leerink Swann | Maintain | Outperform | Outperform |
| 2017-07-20 | Canaccord Genuity | Maintain | Buy | Buy |
| 2017-04-27 | Cowen & Co. | Maintain | Outperform | Outperform |
| 2017-03-27 | Cowen & Co. | Maintain | Outperform | Outperform |
| 2017-02-22 | Roth Capital | Upgrade | Neutral | Buy |
| 2016-10-04 | Jefferies | Maintain | Buy | Buy |
| 2016-08-15 | Goldman Sachs | Maintain | Neutral | Neutral |
| 2016-07-27 | Jefferies | Maintain | Buy | Buy |
| 2016-06-16 | Craig-Hallum | Upgrade | Hold | Buy |
| 2016-05-04 | Mizuho | Downgrade | Buy | Neutral |
| 2016-02-26 | Empire Asset Management | Maintain | Sell | Sell |
| 2016-02-25 | Roth Capital | Downgrade | Buy | Neutral |
| 2016-02-25 | Jefferies | Maintain | Buy | Buy |
| 2016-02-25 | Stephens & Co. | Downgrade | Overweight | Equal Weight |
| 2016-02-24 | Benchmark | Maintain | Hold | Hold |
| 2016-02-24 | Craig-Hallum | Downgrade | Buy | Hold |
| 2015-12-18 | BTIG Research | Maintain | Buy | Buy |
| 2015-10-06 | Benchmark | Maintain | Hold | Hold |
| 2015-10-01 | Craig-Hallum | Maintain | Buy | Buy |
| 2015-08-24 | Canaccord Genuity | Maintain | Buy | Buy |
| 2015-07-23 | Lake Street | Upgrade | Hold | Buy |
| 2015-06-22 | Canaccord Genuity | Maintain | Buy | Buy |
| 2015-05-05 | JMP Securities | Maintain | Market Outperform | Market Outperform |
| 2015-03-26 | Goldman Sachs | Downgrade | Buy | Neutral |
| 2015-02-25 | JMP Securities | Maintain | Market Outperform | Market Outperform |
| 2015-01-05 | Lake Street | Maintain | Buy | Buy |
| 2014-10-31 | Canaccord Genuity | Maintain | Buy | Buy |
| 2014-10-28 | Stephens & Co. | Downgrade | Overweight | Equal Weight |
| 2014-10-13 | Wedbush | Maintain | Neutral | Neutral |
| 2014-10-10 | JMP Securities | Maintain | Market Outperform | Market Outperform |
| 2014-10-09 | Canaccord Genuity | Maintain | Buy | Buy |
| 2014-08-27 | JMP Securities | Maintain | Market Outperform | Market Outperform |
| 2014-08-12 | Canaccord Genuity | Maintain | Buy | Buy |
| 2014-06-04 | Goldman Sachs | Maintain | Buy | Buy |
| 2014-05-30 | Wedbush | Downgrade | Outperform | Neutral |
| 2014-05-02 | JMP Securities | Maintain | Market Outperform | Market Outperform |
| 2013-10-16 | Wedbush | Upgrade | Neutral | Outperform |
| 2013-09-16 | Alere Financial | Maintain | Buy | Buy |
| 2013-07-12 | Jefferies | Maintain | Buy | Buy |
| 2013-05-31 | Jefferies | Maintain | Buy | Buy |
| 2013-04-18 | Canaccord Genuity | Maintain | Buy | Buy |
| 2013-02-21 | Benchmark | Maintain | Speculative Buy | Speculative Buy |
| 2012-12-20 | Roth Capital | Maintain | Buy | Buy |
| 2012-10-16 | Jefferies | Maintain | Buy | Buy |
| 2012-10-12 | Wedbush | Downgrade | Outperform | Neutral |
| 2012-07-18 | Maxim Group | Maintain | Sell | Sell |
| 2012-02-24 | Benchmark | Maintain | Speculative Buy | Speculative Buy |
| 2012-02-24 | Auriga | Maintain | Buy | Buy |